益肾通络法治疗冠心病心律失常的临床研究
|
摘要
目的探讨益肾通络法治疗冠心病心律失常患者的临床疗效。方法选取96例冠心病心律失常患者,按治疗方法不同随机分为治疗组和对照组,治疗组50例,对照组46例。对照组患者行参松养心胶囊治疗,治疗组患者采用益肾通络中药方治疗,对比2组患者的临床治疗疗效。结果 2组患者均未出现不良反应,观察组患者治疗总有效率(92%)与对照组(74%)相比,P<0.05,差异具有显著性。结论应用益肾通络法治疗冠心病心律失常临床疗效显著,安全可靠,无副作用,对临床实践有重要指导价值
Objective To investigate the clinical effect of invigorating kidney and dredging collateral method in the treatment of coro-nary heart disease arrhythmia. Methods According to the different treatment methods, 96 cases of coronary heart disease arrhythmia patients were randomly divided into observation group and control group, with 50 cases in each group. The control group was given Songxin Yangxin capsule, and the observation group was given invigorating kidney and dredging collateral method. The clinical effect of the two groups was compared. Results No adverse reactions were observed in the two groups. The total effective rate of the obser-vation group(92%) and the control group(74%) was compared, and there was significantly difference, P<0.05. Conclusion The invigorating kidney and dredging collateral method in the treatment of coronary heart disease arrhythmia has clinical curative effect, it is safe reliable, no side effects, and has an important guiding value for clinical practice.
Objective To investigate the clinical effect of invigorating kidney and dredging collateral method in the treatment of coro-nary heart disease arrhythmia. Methods According to the different treatment methods, 96 cases of coronary heart disease arrhythmia patients were randomly divided into observation group and control group, with 50 cases in each group. The control group was given Songxin Yangxin capsule, and the observation group was given invigorating kidney and dredging collateral method. The clinical effect of the two groups was compared. Results No adverse reactions were observed in the two groups. The total effective rate of the obser-vation group(92%) and the control group(74%) was compared, and there was significantly difference, P<0.05. Conclusion The invigorating kidney and dredging collateral method in the treatment of coronary heart disease arrhythmia has clinical curative effect, it is safe reliable, no side effects, and has an important guiding value for clinical practice.
引文
[1]苏丹,牛小麟,宋安齐.中药抗心律失常的现状及展望[J].现代中西医结合杂志,2011,20(25):3246-3248.
[2]Roquer J,Rodríguez-Campello A,Gomis M,et al.Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men[J].J Neurol,2006,253(11):1484-1489.
[3]Nattel S,Carlsson L.Innovative approaches to anti-arrhythmic drug therapy[J].Nat Rev Drug Discov,2006,5(12):1034-1049.
[4]惠汝太,滕思勇.心脏电生理学新概念[J].中国循环杂志,2002,17(2):87-88.
[5]杨宝峰,蔡本志.心律失常发病机制研究进展[J].国际药学研究杂志,2010,37(2):81-86.
[6]Murakoshi N,Aonuma K.Epidemiology of arrhythmia sand sudden cardiac death in Asia[J].Circ J.2013,77(10):2419-2431.
[7]史建林,雷刚,杨亚亚.自拟益心汤治疗冠心病心律失常的疗效观察[J].中国卫生标准管理,2015:6(1):64-65.
[8]Zacharia A M,Shyjila P A,Kizhakkethottam J.Cardiac Arrhythmia Classification Using Atrial Activity Signal[J].Procedia Technology,2016,24:1406-1414.
[9]陈伯钧,张文清,张敏州.冠心病中医分型与心律失常及心功能关系分析[J].现代中西医结合杂志,2000,9(19):1857-1858.
[10]Ng GA.Neuro-cardiac interaction in malignant ventricular arrhythmia and sudden cardiac death[J].Auton Neurosci,2016,199:66-79.
[11]郑杨,赵巍.抗心律失常药物的应用现状和前景[J].内科理论与实践,2016,11(1):7-10.
[12]梁峰,胡大一,沈珠军,等.2015年欧洲心脏病协会关于室性心律失常患者治疗和心脏性猝死预防指南的解读[J].中国医院用药评价与分析,2016,16(6):721-727.
[13]韩芬,戴国华,赵晨,等.386例冠心病心律失常住院患者中医药治疗情况调查分析[J].西部中医药,2015,28(3):86-89.
[14]马妍,江丰,崔远武,等.张伯礼治疗心悸经验[J].中医杂志,2014,55(12):1003-1006.
[15]苏凯,杨粤峰,陈学忠.老年心脑血管疾病与肾虚血瘀的相关性[J].河南中医,2011,31(7):708-709.
[16]马妍,江丰,崔远武,等.关于衰老与抗衰老的中医理论探析[J].时珍国医国药,2009,20(12):3173-3175.
[2]Roquer J,Rodríguez-Campello A,Gomis M,et al.Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men[J].J Neurol,2006,253(11):1484-1489.
[3]Nattel S,Carlsson L.Innovative approaches to anti-arrhythmic drug therapy[J].Nat Rev Drug Discov,2006,5(12):1034-1049.
[4]惠汝太,滕思勇.心脏电生理学新概念[J].中国循环杂志,2002,17(2):87-88.
[5]杨宝峰,蔡本志.心律失常发病机制研究进展[J].国际药学研究杂志,2010,37(2):81-86.
[6]Murakoshi N,Aonuma K.Epidemiology of arrhythmia sand sudden cardiac death in Asia[J].Circ J.2013,77(10):2419-2431.
[7]史建林,雷刚,杨亚亚.自拟益心汤治疗冠心病心律失常的疗效观察[J].中国卫生标准管理,2015:6(1):64-65.
[8]Zacharia A M,Shyjila P A,Kizhakkethottam J.Cardiac Arrhythmia Classification Using Atrial Activity Signal[J].Procedia Technology,2016,24:1406-1414.
[9]陈伯钧,张文清,张敏州.冠心病中医分型与心律失常及心功能关系分析[J].现代中西医结合杂志,2000,9(19):1857-1858.
[10]Ng GA.Neuro-cardiac interaction in malignant ventricular arrhythmia and sudden cardiac death[J].Auton Neurosci,2016,199:66-79.
[11]郑杨,赵巍.抗心律失常药物的应用现状和前景[J].内科理论与实践,2016,11(1):7-10.
[12]梁峰,胡大一,沈珠军,等.2015年欧洲心脏病协会关于室性心律失常患者治疗和心脏性猝死预防指南的解读[J].中国医院用药评价与分析,2016,16(6):721-727.
[13]韩芬,戴国华,赵晨,等.386例冠心病心律失常住院患者中医药治疗情况调查分析[J].西部中医药,2015,28(3):86-89.
[14]马妍,江丰,崔远武,等.张伯礼治疗心悸经验[J].中医杂志,2014,55(12):1003-1006.
[15]苏凯,杨粤峰,陈学忠.老年心脑血管疾病与肾虚血瘀的相关性[J].河南中医,2011,31(7):708-709.
[16]马妍,江丰,崔远武,等.关于衰老与抗衰老的中医理论探析[J].时珍国医国药,2009,20(12):3173-3175.